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Abstract
The opportunistic pathogen Candida albicans is a frequent inhabitant of the human gastrointestinal tract where it usually
behaves as a harmless commensal. In this particular niche, it needs to adapt to the different micro environments that
challenge its survival within the host. In order to determine those factors involved in gut adaptation, we have used a
gastrointestinal model of colonization in mouse to trace the behaviour of fungal cells. We have developed a genetic
labelling system based on the complementary spectral properties of the fluorescent proteins GFP and a new C. albicans
codon-adapted RFP (dTOM2) that allow a precise quantification of the fungal population in the gut via standard in vitro
cultures or flow cytometry. This methodology has allowed us to determine the role of the three MAP kinase pathways of C.
albicans (mediated by the MAPK Mkc1, Cek1 or Hog1) in mouse gut colonization via competitive assays with MAPK pathway
mutants and their isogenic wild type strain. This approach reveals the signalling through HOG pathway as a critical factor
influencing the establishment of C. albicans in the mouse gut. Less pronounced effects for mkc1 or cek1 mutants were
found, only evident after 2–3 weeks of colonization. We have also seen that hog1 mutants is defective in adhesion to the gut
mucosa and sensitive to bile salts. Finally, we have developed a genetic strategy for the in vivo excision (tetracycline-
dependent) of any specific gene during the course of colonization in this particular niche, allowing the analysis of its role
during gut colonization.
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Introduction
The fungal pathogen C. albicans is a common inhabitant of
certain body locations, such as the gastrointestinal and vaginal
tracts, where it frequently behaves as a harmless commensal;
however, an alteration of host defense mechanisms may lead to a
pathogenic behavior of the fungus. Under certain circumstances,
this process may involve the translocation of the fungus to the
bloodstream from these reservoirs, reaching essential organs and
causing severe diseases. Despite the increasing importance of non-
Candida and non-albicans species [1], this fungus is the 4th leading
cause of nosocomial infections, representing a primary health
problem in several countries that is partially aggravated by the
relatively limited antifungal therapy available [2,3]. Several
approaches have been developed to understand its mechanisms
of virulence, although the concept of virulence may not be easy to
be defined for ‘‘pathobionts’’ [4–6]. Development of genetic tools
for this fungus (see [7] for a recent review) has allowed,
nevertheless, the identification of several ‘‘virulence’’ factors,
mainly using the mouse intravenous model to test their role during
a systemic infection. They include adhesion molecules that
facilitate the interaction with the host cells, metabolic or
nutritional traits that optimize growth in vivo and several other
factors that facilitate invasion. The ability to switch between
different morphologies (called polymorphism) is also an important
feature that influences pathogenicity as it facilitates tissue
penetration and escape from phagocytes [8,9]. Factors affecting
C. albicans commensal colonization of different mucosal surfaces
may represent an alternative promising approach in the control of
candidiasis [6,10]. In fact, high fungal gastrointestinal levels may
be an important predisposing factor towards acquired Candida
infections [11], which come mainly from endogenous origin [12].
Although some non-vertebrate models have been developed in the
last years to analyse fungal virulence [13], the use of mammals
becomes more relevant when considering the similarity between
the immunological system and the routes of infection of rodents
and humans. Commensalism models [14] are acquiring increasing
relevance compared to the standard systemic models. These
models make use of either neonatal or adult immunocompromised
mice or animals partially depleted in the gastrointestinal micro-
biota by the use of a broad spectrum antibiotic therapy [15].
Combined genetics and transcriptional analyses have revealed the
role of certain metabolic traits [16], transcription factors [17,18]
and phenotypic switch-related genes [19] in the adaptation to the
gastrointestinal niche.
Mitogen-activated protein kinase (MAPK) pathways represent
one of the main mechanisms of adaptation to environmental
changes in C. albicans. These signaling pathways are present in all
eukaryotic cells and sense changes on different situations like
osmotic, oxidative or nitrosative stress, pH alterations, tempera-
ture, nutrient starvation or when cell wall damage is induced by
certain drugs (i.e. Congo Red, azoles, and cell wall synthesis
inhibitors). Upon perception of an external stress, via a membrane
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receptor, they generate a signal by sequential phosphorylation that
finally leads to an adaptive response via specific transcription
factors. Previous work from our group -and other laboratories- has
shown that MAPK mediated signaling pathways play an
important role in virulence (see [20,21] for recent reviews). This
concept fits well with the existence of specific conditions on certain
body locations during infection [22,23]; in fact, oxidative stress is a
common challenge for any pathogen as immune cells like
macrophages and neutrophils continuously sample microbial cells
and destroy them [24]. In C. albicans, three main MAPK pathways
have been characterized. The cell integrity pathway involves the
Mkc1 MAPK [25] and participates in cell wall construction and
host interaction [26–28]. The HOG pathway relies on the Hog1
MAP kinase, enabling adaptation to both osmotic and oxidative
stress [29–32]; this route, however, also participates in the
biogenesis of the cell wall [29,33–35]. Finally, the Cek1 kinase
participates in morphogenesis, invasion and cell wall biogenesis
[36,37]. Despite this apparently pleiotropic nature, each pathway
responds to specific stimuli and generates a rather specific
response, although it is clear that several cross talk mechanisms
exist among them [38,39]. Genetic analysis has revealed that
mutants defective in each pathway show a reduced virulence in the
standard mouse systemic model of infection and some of them also
show reduced virulence on certain alternative models of virulence
[20].
We are interested in studying the role of these MAP kinases
routes in a model of sustained gut colonization [40] and we have,
therefore, extended this model to specific conditions where long-
term high-level C. albicans sustained colonization is achieved; in
our model, two different strains can be assessed together and easily
detected by both culture-dependent and independent methods.
We demonstrate, using this methodology, that mkc1 and cek1
mutants are defective in long term sustained colonization while the
absence of a functional HOG pathway results in a complete failure
to establish and to maintain stables fungal loads in the gut,
indicating that the signaling through this route is a critical adaptive
mechanism to colonize the mouse gastrointestinal tract.
Materials and Methods
Ethics Statement
All the animal experiments performed in this work were carried
out in strict accordance with the regulations in the ‘‘Real Decreto
1201/2005, BOE 252’’ for the Care and Use of Laboratory
Animals of the ‘‘Ministerio de la Presidencia’’, Spain. The protocol
was approved by the Animal Experimentation Committee of the
University Complutense of Madrid (Permit Number: BIO2012-
31839-1). None of the treatments resulted in noticeable disease in
the animals as determined by external or internal (post mortem)
examination, still all efforts were made to minimize suffering. Mice
euthanasia was performed by CO2 inhalation following standard
protocols (AVMA Guidelines for the Euthanasia of Animals: 2013
Edition). The number of animals used in the experimentation was
minimized for ethical reasons.
Strains and growth conditions
All C. albicans strains used in this work, listed in Table S1, derive
from the SC5314 clinical isolated [41]. The parental strain CAF2
is referred here as wild type control [42]. Strains defective in
MKC1, CEK1 or PBS2 genes were described elsewhere [25,43,44].
Conditional and mutant HOG1 strains are described in the next
section.
Yeast strains were routinely short-term stored at 4uC and grown
at 37uC in YPD medium (2% glucose, 2% peptone, 1% yeast
extract) or SD medium (2% glucose, 0.5% ammonium sulphate,
0.17% yeast nitrogen base) plus amino acids and chloramphenicol
(10 mg/mL). When necessary, to regulate the TET expression
system, 20 mg/mL doxycycline (Sigma) was added to the medium.
Nourseothricin was added (200 mg/mL) for selection of C. albicans
transformants. Drop tests were performed by spotting 5 mL drops
of 10-fold serial dilutions of stationary grown cells onto YPD plates
supplemented with bile salts (Sigma) or SDS (Duchefa Biochemie)
at the indicated concentrations. Plates were incubated for 48 h at
37uC and scanned for figure assembly.
Plasmids were propagated in Escherichia coli strain DH5a. E. coli
strains were grown in LB medium either with ampicillin (100 mg/
mL) or chloramphenicol (20 mg/mL) according to the plasmid
marker.
Molecular biology procedures and plasmid constructions
pNIM1R, which allows a repressible tetracycline-dependent
regulation (TET-OFF) in C. albicans, was kindly provided by Dr.
L.E. Cowen (unpublished data). Adapted GFP [45] was obtained
from pNIM1_MoGFP_carboxi_ca_myc [46] by digestion with
SalI-BglII restriction enzymes. This piece of DNA was ligated with
a SalI-BglII fragment from pNIM1R to generate pNIM1R-GFP.
A red fluorescent protein (RFP) suitable for expression in this
fungus (called here C. albicans dTOM2, Figure S1) was synthesized
by codon optimization of the DsRed-derived RFP dTomato gene
[47] based on codon usage of four highly expressed C. albicans
genes (HWP1, ENO1, MRPS9 and ACT1) as template (GenScript,
USA). The dTOM2 gene was cloned into pNIM1R by replacing
the GFP fragment after digestion with SalI and NotI restriction
enzymes, therefore generating a tetracycline-repressible RFP
plasmid. Both pNIM1R-GFP and pNIM1R-dTOM2 were used
to generate fluorescent labeled strains. Products of plasmid
digestion with KpnI and KspI, that directs integration at the
ADH1 region of wild type or mutant strains of C. albicans, were
transformed by electroporation and transformants were selected as
nourseothricin resistant clones. Strains’ genotype was confirmed
by PCR analysis.
To obtain the plasmid pNIM1-FLP-URA3 (flippase gene
expressed under TET-ON regulation), plasmid pNIM1 [48] was
digested with SalI and AvaI restriction enzymes and ligated with a
FLP-URA3 AvaI fragment. The latter was amplified from
pSFL213 [49] using the primers o-FLPURAup (AGGCTCGA-
GATGTCACAATTTGATATATTATGTAAAAC) and o-
FLPURAlw (TCCCCCGAGTTATAATTGGC-
CAGTCTTTTTCAAAT).
The hog1 mutant used in this work was obtained following the
standard URA3-blaster method [42] in a CAI4 strain [42] instead
of our previous published hog1 mutant (in RM1000 background)
[50] to avoid side effects due to chromosome 5 aneuploidy [51].
The HOG1cR strain was generated as follows. First, a hog1 mutant
was transformed with a DNA construct in which the HOG1 gene
was flanked with FRT (flippase recognition target) recombination
sites that directed this piece of DNA to the ARD1 locus [52], thus
obtaining the strain HOG1fR. Then, the FLP gene expressed
under TET-ON system in pNIM1-URA3-FLP was introduced by
homologous recombination at the ADH1 region using enzymes
KpnI and KspI, as previously described.
In vivo procedures
Female mice C57BL/6 were obtained from Harlan Laborato-
ries Inc. (Italy) and used within an age of 7 to 10 weeks-old. Mice
housing and other non-invasive procedures took place in the
animal facility from the Medical School of the Universidad
Complutense de Madrid.
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Colonization assays to test the establishment of C. albicans
commensal in the gut began with a four days antibiotic
pretreatment followed by a single gavage of 107 yeast cells in
100 mL of sterile PBS. Unless otherwise indicated, the standard
antibiotic treatment in sterile drinking water consists of 2 mg/mL
Streptomycin (Sigma), 1 mg/mL Bacitracin (Sigma) and 0.1 mg/
mL Gentamicin (Sigma) as described elsewhere [40]. Fresh stool
samples were periodically collected (every 2–4 days) from each
individual and mechanically homogenized in PBS to quantify the
fungal population by Colony Forming Units (CFUs) determination
on SD-agar plates. For flow cytometry analysis, the homogenized
stool samples were immediately filtered through a 40 mm-cell
strainer nylon filter (BD) prior to its analysis in a Guava EasyCyte
cytometer. Samples were fixed using a 1% formaldehyde solution
for 30 minutes at 4uC. To determine C. albicans population in
different gut locations, mice were sacrificed and intestinal tracts
were aseptically exscinded. Samples from cecum, small and large
intestine were homogenized in sterile PBS and 10-fold serial
dilutions were cultured to determine C. albicans CFUs.
FACS and microscopy analysis
Epifluorescence microscopy images were obtained from an
Eclipse TE2000-U inverted microscope (Nikon) coupled with an
Orca C4742-95-12 ER Charge Coupled Device camera (Hama-
matsu). Capture and image processing were performed with
AquaCosmos Imaging System 1.3 software. Guava EasyCyte
cytometer and InCyte software (Millipore) were used for flow
cytometry qualitative and quantitative analysis of fluorescence
labeled C. albicans strains.
Ex vivo adhesion assay to intestine mucosa
For the ex vivo adhesion assay, a 1 cm-piece of the large intestine
was obtained from a recent euthanatized mice. This piece was
longitudinally opened, carefully washed with sterile PBS and
placed in a 4 mm-diameter methacrylate chamber filled with
RPMI media pre-warmed at 37uC. C. albicans cells from an
overnight YPD culture were suspended in RPMI serum-free
media at a concentration of 2.56107 cells/mL. The lumen side
from the colonic tissue was inoculated with 106 yeast cells an
incubated for 150 minutes at 37uC. After this period, the piece of
intestine was carefully washed with sterile PBS twice and
mechanically disaggregated. C. albicans cells recovered from the
latter fraction were considered as adhered and further analysed by
CFU standard determination.
Statistical analysis
Statistical differences among two groups were calculated using
Student’s two-tailed unpaired t-test. Data are expressed as each
replicate and median (colonization assay) or mean 6 standard
deviation (adhesion assay).
Results
Dual fluorescence genetic labelling allows C. albicans
discrimination in mouse fecal samples
In order to determine the behavior of mutant strains of C.
albicans in the gut, we devised a competitive assay that would allow
a precise determination of fitness within the gastrointestinal tract.
In this scheme, two strains are labeled with different and
distinguishable fluorescent proteins so the evolution of the
population can be determined by analysis of the intestinal content
or stool samples. Since its adaptation to C. albicans, green
fluorescent protein (GFP) has been broadly used in genetics [53],
allowing precise detection of gene expression in cells by both
fluorescent microscopy and flow cytometry [45,54]. We have used
in this work the GFP allele from Dr. J. Morschha¨user [45], called
MoGFP or simply GFP. In order to use a complementary
fluorescent marker, we adapted the DNA sequence of the RFP
dTomato [47] (see Material and Methods). The expression of this
gene from the tetracycline-dependent integrative plasmid
pNIM1R allowed detection of cells expressing the RFP in vitro,
in the absence of doxycycline on liquid media in both yeast and
hyphal forms (Figure 1A). No signal was detectable when
doxycycline was present in the medium (not shown) in accordance
with the tight regulation of this system in yeast [55]. Expression in
C. albicans was also detectable in SD plates as pink-reddish colored
colonies after two days of growth and these colonies were clearly
distinguishable from GFP-expressing ones on a plate (Figure 1B).
When samples were taken from mice colonized with a mixed
population of both CAF2-GFP and CAF2-dTOM2, microscopic
examination of fresh stool samples also allowed the identification
of GFP and dTOM2 expressing cells (Figure 1C). We also
analysed fecal samples using a protocol for flow cytometry in order
to achieve an instantaneous culture-independent analysis (see
Material and Methods). FACS analysis of stool samples showed
the appearance of a positive population for each signal, either in
the green (GFP) or yellow (RFP) channel, which were not observed
in similar samples from non-colonized control mice (Figure 1D).
Mean fluorescent intensities under these conditions were 126 for
dTOM2 (yellow channel) and 667 for GFP (green channel),
enough to distinguish from non-labeled controls (means of 16 and
14 in yellow and green channels, respectively) in dot-plot or
histograms (Figure 1D). In non-colonized mice, common events,
that would correspond to microbiota population with varying
degrees of autofluorescence, were detected (Figure 1D, upper small
dot-plot). This analysis could be prolonged in animals colonized
for up to 60 days with similar results (data not shown) indicating its
independence on the timing of gut colonization. We also found a
good correlation of the quantification of the population between
both culture dependent (standard CFU counting) and independent
(flow cytometry) measurements (Figure S2A). These results
indicate that genetic labelling allows a precise in vitro and ex vivo
quantification and analysis of populations of C. albicans strains
colonizing the mouse gut.
Gut adapted C. albicans cells are not able to compete
with unaltered endogenous microbiota
The ability of C. albicans to colonize murine gastrointestinal tract
has been studied by some authors, revealing the need of
diminishing the bacterial microbiota to allow the establishment
of this fungus within the gut [14,40]. In some of these models,
stable long-term C. albicans gut colonization is achieved if oral
antibiotic therapy is established before a single gavage of this
fungus in mice and maintained along the experiment. We have
studied the role of antibiotic therapy both in the establishment and
in the maintenance of C. albicans colonization.
First, we have determined the relevance of C. albicans adaptation
during long term colonization. For this, we kept this fungus
colonizing mice for 6 weeks (43 days) to allow a long term
adaptation to the commensal state in the presence of antibiotic
therapy that was then removed (Figure 2A, grey arrow).
Suppression of oral antibiotic therapy led to an immediate loss
of fungal population in stool samples, which were barely detectable
after additional 15 days. The kinetics of fungal loss indicates an
almost lineal drop of 0.306 logarithmic units per day in the fungus
content per gram of feces (r2 = 0.98). This event was reversible if
the fungus was not completely absent from the animals since oral
antibiotic reestablishment (black arrow) allowed recovering
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original high levels colonization without additional inoculation of
C. albicans cells (Figure 2A). The increase in colonization was
estimated to be 0.273 logarithmic units per day (r2 = 0.73).
In a separate experiment, we confirmed the fate of ingested C.
albicans cells in non-antibiotic treated mice by counting CFUs in
stools shortly after ingestion. As seen in Figure 2B, doses up to 107
Figure 1. Detection of C. albicans GFP and dTOM2 in vitro and in fecal samples. A) Phase contrast (left) and fluorescence (right) images
showing the expression of dTOM2 in exponentially growing cultures of CAF2-dTOM2 strain in YPD (upper panel) or YPD supplemented with 10%
serum (lower panel). Bar indicates 10 mm. B) Appearance of colonies from a pure CAF2-dTOM2 (left, dTOM2) or a mixed CAF2-dTOM2/CAF2-GFP
culture (right, dTOM2/GFP) in SD plates after 2 days of growth at 37uC. C) Detection of fungal cells in four different fecal samples by fluorescence
microscopy. Left, phase contrast; center, green channel and right, red channel. Bar indicates 10 mm. D) Flow cytometry profile of a fecal sample from a
mouse simultaneously colonized with two different labelled fluorescent C. albicans strains. Main panel shows the dot-plot with green (GFP) and red
(dTOM2) populations while the panels below show the histograms of the correspondent gated regions (circled), shown as a coloured filled histogram,
with a histogram from an unlabelled control (empty histogram). As additional control, a dot-plot of a fecal sample from a non-colonized mouse is
shown in the upper part of the figure (control).
doi:10.1371/journal.pone.0087128.g001
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cells did not end up in sustained colonization; rather, a transient
passage through the gastrointestinal tract was observed. At initial
days a few individuals (1 to 3 out of 6) showed a value of
log10CFUs around 2.2, slightly above the limit of detection in these
analyses. These data indicate that, albeit transient, a low level of C.
albicans (,103 CFU/g) does indeed exist. Although this is an
erratic short-term colonization and no fungus was detectable later
on, we tried to discard the existence of cryptic low latent
colonization of C. albicans in mice. Treatment with oral antibiotics
at day 31 did not end up with an increase in C. albicans population
to detectable levels, even though this event was observed in the
previous experiment when antibiotic therapy was reestablished
(Figure 2A). These data collectively indicate that normal mice
microbiota is an effective barrier for the establishment of C. albicans
within the mice gut even when the fungus is already adapted to the
gut niche.
Mutants defective in the HOG pathway are unable to
establish gut colonization
Previous studies have revealed a role for the MAP kinases
pathways in virulence in C. albicans in models of systemic infection.
We addressed here the importance of C. albicans MAPKs in its
ability to establish colonization within the mouse gut applying the
model described. For this kind of experiments, a mixed population
of a wild type and mutant strain expressing either dTOM2 or GFP
were administered by gavage to antibiotic treated mice. The
population from stools was subsequently analysed on SD plates,
discriminating each strain population by the different colony
pigmentation. We first confirmed in vitro that expression of either
Figure 2. Effect of antibiotic therapy upon C. albicans gut colonization in mice. C. albicans colonization assays. CFUs from each individual
are represented as open circles, while the line reflects the tendency of the median. Horizontal dashed line refers to the detection limit. A) Oral
antibiotic therapy (streptomycin, bacitracin and gentamicin) was given to mice (n = 4) from 4 days before a gavage of 107 C. albicans wild type cells
(day 0) and maintained until day 43 when it was removed (grey arrow) and restored again on day 62 (black arrow). B) Mice (n = 6) were gavaged with
107 C. albicans wild type cells and analysis of CFUs in stools was followed as a function of time. Oral antibiotic therapy was administered from day 31
(black arrow).
doi:10.1371/journal.pone.0087128.g002
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GFP or dTOM2 did not significantly alter the behaviour of C.
albicans as the duplication time in exponentially growing phase was
not altered (67 min for all strains,Figure S2B), either in the
presence or absence of 20 mg/mL doxycycline which regulates the
expression of fluorescent proteins. In addition, a 50% mixed
population of wild type cells (CAF2-dTOM2 and CAF2-GFP) did
not result in a substantial reduction of the percentage of either
GFP or dTOM2 expressing C. albicans cells in SD cultures in vitro
(Figure S2C) even after a significant number of duplication times
(.50 generation times) during 11 sequential exponential growths.
This mixed population also behaved neutral in an in vivo
colonization experiment in mice (Figure S2D).
We therefore tested the MAPK mutants in this model. As shown
in Figure 3, the relevance of each MAPK in gut establishment is
clearly different. The behaviour of cek1 and mkc1 mutants was
similar, reaching levels comparable to the wild type strain at early
time points (day 1) but gradually disappearing after 2-3 weeks
(Figures 3A and B). In stark contrast, hog1 mutants were unable to
establish within the gut when co-inhabiting with the parenteral
strain (Figure 3C). In fact, we were only able to detect very low
levels of hog1 mutant cells (in the range of 103–104 CFU/g) and
only at the earliest time points (days 1 and 2). This kinetic is
consistent with simple intestinal transit but not establishment as
occurs with non-antibiotic treated mice. To assess whether this
phenotype is characteristic of HOG pathway activation, we tested
the behaviour of pbs2 mutants (which are defective in the Hog1-
specific activator MAPKK [44]). While there were certain
differences (pbs2 population peaked higher at 105 CFUs/g than
those of hog1 mutants) the maximum CFU detection also took
place at day 1 and disappeared in about 3 days (Figure 3D).
We wanted to confirm that colonization impairment also takes
place in the absence of wild type cells. When a GFP-labeled hog1
strain was inoculated to colonize mouse gut under standard
conditions, it reached a colonization level of 106 CFUs/g constant
over a period of 6–8 days. Afterwards, it showed a gradual
decrease in population detected from individuals stools until day
20 (reduction of 0.324 logarithmic units per day in the fungus
content per gram of feces, r2 = 0.96) followed by high variable
values, most of them around or below our detection limit
(Figure 4).
Since in this experiment we lacked an internal control, we
wondered if this failure to colonize was due to the hog1 phenotype
or an artifact caused by a physiological change in the animals or
the selection of an intrinsically competitive microbiota. This does
not seem to be the case, since inoculation of two separated mice
from this group with a wild type CAF2-dTOM2 strain still allowed
a high level (standard) colonization (Figure 4, open circles), while
after re-inoculation the rest mice of group with a fresh hog1-GFP
strain (obtained from in vitro culture), did not allow detection of
fungal cells in stool samples in the following days (Figure 4, open
triangles).
HOG1 expression is necessary for long term colonization
of C. albicans to the mouse gut
Due to the defects present in the hog1 mutant that impair
initiating gut colonization, it is difficult to assess whether Hog1 has
an actual role in the maintenance of C. albicans in the gut. We
devised a complementary strategy for checking the behaviour of a
fungal population in which excision of HOG1 gene is induced in
vivo in the gut. To obtain a HOG1 conditional mutant, we
transformed a hog1 mutant strain with a construction in which the
HOG1 gene and the SAT1 (nourseothricin marker) were flanked by
flippase FRT repeats [52] and ectopic expression of the FLP
recombinase gene was dependent on a TET-ON expression
system (see Material and Methods and Figure S3B). This strain,
HOGcR, reverts in vitro the main hog1 phenotypes such as osmo-
sensitivity and oxidative stress sensitivity unless FLP is induced by
doxycycline addition to the medium (data not shown). We
previously checked that the TET-ON system efficiently expresses
GFP in vivo (Figure S3A), so we expected that administration of
tetracycline (in this case autoclaved chlortetracycline or aCT, a
tetracycline derivate that lacks most of the antibiotic activity)
would trigger an efficient in vivo FLP-mediated HOG1 excision.
This process occurred very efficiently in vitro on cells growing in
YPD-20 mg/mL aCT with more than 99% of cells showing osmo-
sensitivity (hog1 phenotype) after 48 hours, (Figure S3C).
Upon oral colonization, HOGcR showed standard levels of
colonization, reaching values up to 106–107 cells/g in stool
samples, with all cells (.99,9%) showing a wild type phenotype
(osmo-resistance). However, from the first day after instauration of
aCT therapy (yellow arrow), we observed the appearance of CFUs
with a hog1 phenotype (osmo-sensitive) from stools, even though a
osmo-resistant wild type population remained almost constant
(Figures 5A and B). Osmo-sensitive population levels were around
105 CFUs/g, still 10 fold less than wild type cells (around
106 CFUs/g) and were constant over the entire period where
the aCT therapy was maintained (Figures 5A and B), but it rapidly
disappeared once aCT was removed from oral treatment
(Figure 5A, grey arrow). Analysis postmortem of intestinal samples
revealed that in all gut locations (small and large intestine and
cecum), the proportion among HOG1-excised and non-excised
populations remained nearly the same (Figure 5C). However, it is
important to notice that osmo-resistant colonies recovered from
these mice were not refractory to FLP expression, since excision of
HOG1 could be efficiently achieved in vitro by aCT (data no
shown). A explanation for this behaviour would be that FLP
mediated excision is not completely efficient in vivo and that
mutant cells do not outcompete wild type cells, further demon-
strating an important role for Hog1 also once high fungal loads
have been already established.
Hog1 role in mucosa adhesion and in vitro resistance to
the gut surroundings
We tried to determine the factors that could explain defects in
colonization in the gastrointestinal tract. We tested in vitro the
sensitivity of hog1 to different ranges of pH and trypsin or
pancreatic lipase activities, all of which may have a significant
implication in gut colonization or passage through the intestinal
tract. Although in these cases no differences were observed when
comparing to the wt (data not shown), the hog1 mutant was
interestingly found to be sensitive to bile salts (Figures 6A and S4)
being unable to grow at concentrations of 0.1%. A similar
behaviour was seen for the ionic detergent SDS. Both phenotypes
are also present in the pbs2 mutant (data not shown), therefore
suggesting that bile salts are a potential mechanism controlling
fungal colonization that cannot be compensated in the absence of
Hog1 activation.
We also tested the ability of hog1 and pbs2 mutants to adhere to
the mouse gut. For this purpose we developed a competitive
screening that can efficiently determine the behaviour of two
differentially labeled strains. In our novel ex vivo adhesion assay,
both hog1 and pbs2 cells showed a clear reduction in the adhesion
to gut mucosa, with an Adhesion Relative Index of 0.67 (hog1) and
0.65 (pbs2) vs. 0.89 in CAF2 (p,0.05) after 150 minutes of
interaction (Figure 6B). These results point out that hog1 altered
adhesion may contribute for its defective gut colonization.
Candida albicans HOG Pathway in Mouse Colonization
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Discussion
Gastrointestinal models of colonization [14] are an excellent
way to analyse C. albicans-host interactions. While these models are
still defective in simulating certain aspects of human pathogenesis
(such as too high fungal levels), they more closely mimic the
normal route by which C. albicans accesses the bloodstream causing
invasive diseases. They therefore provide an opportunity to
analyse those factors influencing not only host tissue damage,
but also those related to colonization and dissemination. Parallel
with this development, it is necessary to improve methods to
analyse the behaviour of fungal populations in the gut. For this
main purpose, we have developed in this work an ex vivo flow
cytometry-based methodology that is due to the complementary
spectral properties of fluorescent proteins expressed in C. albicans.
Both dTOM2 and GFP (used here) are stable enough to provide a
strong signal, despite the reduced availability of oxygen within this
particular niche, and allow differentiation of fungi from bacterial
cells and other intestinal debris. Our data indicate that there is an
overall good correlation between cytometry and standard CFUs
counts, suggesting that -most likely- fungal gut content represent
alive cells. An important technical feature of this method is that it
may allow direct ex vivo analysis of specific parameters in fungal
cells (in stools or gut content) without further manipulations (such
as growth on liquid or solid cultures) that could hinder their
physiological status. While bacterial content of human stools has
been analysed by flow cytometry [56], several authors have
revealed the existence of fungi in experimental mice gut just using
microscopic analysis by staining the samples with calcofluor white
[57] or specific antibodies [58,59] or DNA probes [59]. This is, to
our knowledge, the first demonstration that fungal population can
be efficiently traced in stools ex vivo by flow cytometry. It therefore
provides an opportunity to quantify parameters such as oxidative
stress, metabolic status and cell wall architecture in situ, which can
differ substantially from those obtained from in vitro cultures. In
fact, a recent study describes how passage through the gastroin-
testinal tract triggers in C. albicans a developmental program that
enables adaptation to the commensal state that significantly
changes the morphology and transcriptional status of the cell [19].
Using this methodology -as well as the standard CFU counts-,
we have further characterized the role that mice microbiota plays
during C. albicans commensalism. In this model, where stable
Figure 3. Fitness of MAPK mutants in C. albicans in gut colonization. Competition colonization assays with MAPK mutants. CFUs from each
individual are represented as open red circles (CAF2-dTOM2) or green symbols (mutant-GFP). Colored lines reflect the tendency of the median of the
respective strain. Oral antibiotic therapy (streptomycin, bacitracin and gentamicin) was given to mice (n = 4–6) from 4 days before a gavage of 107
cells in a 1 1 mixture of CAF2-dTOM2 and mutant-GFP (day 0). CFUs were counted and associated with each strain based on their pattern of
fluorescent protein expression on solid SD plates. Mutants assessed were A) cek1 (diamonds), B) mkc1 (squares), C) hog1 (triangles) and D) pbs2
(inverted triangles).
doi:10.1371/journal.pone.0087128.g003
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colonization levels of<107 yeast cells/g of feces for several months
is achieved without noticeable damage or pathogenesis to the host,
reduction of intestinal microbiota is critical to allow C. albicans
establishment in the gut [14,15,40]; however, previous studies did
not reveal whether antibiotic therapy was required in already
established C. albicans cells. We have found that, despite
maintaining long-term high level colonization (106–107 CFU/g
for up to 43 days), once antibiotic therapy is depleted there is a
sharp drop in the detection of C. albicans in stools to levels of about
200 yeast cells/g after 14 days, indicating that mouse microbiota
efficiently outcompetes with the already and long term-adapted C.
albicans cells. This process is reversible and restoration of the
antibiotic therapy allows high levels of fungus population in feces.
While our data normally refers to analysis of viable cells in stools,
that would not necessarily correlate with intestinal loads, but in
our experience post mortem analysis of animals reveals a good
correlation between both types of samples. Our data also reveal a
failure to colonize mouse gut after establishment of the antibiotic
therapy once CFUs counting drops behind our limit of detection
(around 1.76102 CFU/g in stools), in accordance with the data
obtained by Kinneberg at day three after orally inoculation of C.
albicans [40]. Furthermore, addition of oral antibiotic treatment to
those mice did not show any presence of C. albicans, while re-
inoculation by gavage of 107 cells at this moment does efficiently
restore high fungal loads (data not shown). These observations
strongly suggest that C. albicans cells do not actually persist in the
mouse gut in a cryptic location and/or status when outcompeted
by commensal microbiota. This is also consistent with the fact that
this fungus is not a normal member of mice commensal microbiota
while C. tropicalis is [60].
Having developed this model, we have determined the role that
MAPK signaling may play in colonization. For this purpose, we
established a competitive methodology in which two different
labeled C. albicans strains are allowed to start colonization in the
mouse gut. Expression of different fluorescent markers using the
TET-OFF system does not significantly influence their in vitro or in
vivo fitness in this particular niche, making them appropriate for in
vivo analysis. However, this methodology does not allow screening
a large number of mutants, as occurs with bar-coded strain
collections [61,62]. The latter strategy is useful for systemic
screening of several mutants and has been shown valuable for the
identification of virulence determinants [63] and transcription
factors influencing commensalism [17]; however, simultaneous
screening of large mutant collections require a parallel reduction
in the starting number of individual clones, which could generate a
‘‘bottleneck’’ effect in these type of studies maybe influencing their
outcome. Assessing individual clones via our fluorescent genetic
labeling is therefore a valuable (and not as costly as qPCR)
complementary tool. Such in deep studies have revealed the role
that certain factors like EFH1 play in the gastrointestinal tract
while not having such role during a systemic infection [18]. A
similar strategy has been used to analyse the role of the mating
type locus (MTL) in virulence and competitiveness in a mouse
systemic model by comparing either unlabeled or GFP-labeled
strains that were homozygous or heterozygous for MTL [64].
We have addressed here the role that three MAPK pathways
play in mice gut colonization. Both the SVG and cell integrity
pathway seem to have a similar role in gut establishment by C.
albicans since both MAPK mutants (cek1 and mkc1) strains show a
similar phenotype. These two signaling routes have been related to
the response to cell wall damage [25,26,34,65,66], suggesting that
this phenotype could be responsible for this behaviour. However,
we have focused on the HOG pathway as this one is critical for
colonization of mice, since mutants in this pathway are unable to
establish or maintain high fungal burdens. We have demonstrated
this not only by the use of mutants defective in the pathway (hog1
and pbs2) but also by the development of a genetic strategy where
in vivo (in gut) deletion of the analysed gene is accomplished, a
strategy similar to the FLP-mediated excision of the URA3 marker
that allows measuring transcriptional activity in the gut [19]. The
scarce detection of mutant hog1 cells during competition in
colonization, only in the first few days, indicates transient passage
Figure 4. Gut colonization of the hog1mutant. C. albicans hog1 mutant colonization assay. CFUs from each individual are represented as green
triangles (hog1-GFP) or red circles (CAF2-dTOM2), open symbols refer to the analysis after the re-inoculation of the respective strains on day 35 (blue
arrow). Colored lines reflect the tendency of the median of the respective strain. Oral antibiotic therapy (streptomycin, bacitracin and gentamicin) was
given to mice (n = 5) from 4 days before a gavage of 107 cells of hog1-GFP (day 0). hog1-GFP and CAF2-dTOM2 strains were inoculated (107 cells) on
day 35 after splitting the group of mice into two separate cages (blue arrow). CFUs were counted and associated with each strain based on their
pattern of fluorescent protein expression on solid SD plates.
doi:10.1371/journal.pone.0087128.g004
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through the gastrointestinal tract but not true colonization. It must
be emphasized that while hog1 mutants are unable to establish in
the gut in the presence of similar amounts of wild type cells, they
can do it in its absence reaching high fungal loads for about 10
days. This could suggest the existence of either defined and limited
niches within the gut where C. albicans wild type proliferation can
take place (competing and therefore, displacing hog1 mutant cells)
or a clear fitness defect for hog1 mutants in vivo. At the moment, we
can only speculate about the reasons for this behaviour. Oxidative
and osmolarity stress are main mechanisms for the activation of
Figure 5. In vivo excision of HOG1 gene during colonization. A-B) C. albicans HOGcR strain colonization assay. CFUs from each individual are
represented as closed diamonds (wt-phenotype) or open triangles (hog1-phenotype). Lines reflect the tendency of the median of the respective
population. Oral antibiotic therapy (streptomycin, bacitracin and gentamicin) was given to mice (n = 3–4) from 4 days before a gavage of 107 cells of
HOGcR strain. Autoclaved chlortetracycline (1 mg/mL aCT) was added to oral treatment to induce the expression of FLP gene (yellow arrow) or
removed in order to stop it (grey arrow). CFUs were counted and associated with each population based on their pattern of osmo-sensitivity on 1.5 M
sorbitol solid YPD plates and confirmed by nourseothricin sensitivity. C) Intestines from mice in Figure 5B were dissected on day 30 and each location
was homogenized and analysed in fungal content. CFUs were counted and associated with each population based on their pattern of osmo-
sensitivity on 1.5 M sorbitol solid YPD plates and confirmed by nourseothricin sensitivity. Black colums refers to CFUs population showing wt-
phenotype, while white columns refers to hog1 phenotype-population. SI = small intestine.
doi:10.1371/journal.pone.0087128.g005
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the HOG pathway and hog1 strain is sensitive to both oxidative
and osmotic stress [30]. It has been shown that a highly anaerobic
environment can lead to transient ROS production [67] and,
moreover, hog1 cells are more efficiently killed by promyelocytic
cells and macrophages in vitro [52], suggesting that mucosal
phagocytes may be an important factor controlling establishment
of the fungus. Alternatively, osmolarity could be important within
certain locations of the lumen although this remains to be
determined experimentally. Another important feature revealed in
this work is the sensitivity to bile salts and SDS, a novel phenotypic
trait characteristic of hog1 mutants that could contribute to its
altered colonization. However, we have seen that a hog1 mutant is
able to survive in the gut for few days when inoculated alone and
also that hog1-phenotype cells from HOGcR strain are found in
similar proportion in all gut locations analysed. This suggests that
there is no correlation with bile salts concentration in the gut,
arguing against this factor being the main mechanism determining
colonization. Besides, it has been seen, by microscopic examina-
tion of mouse gut tissues, that a layer of fungus exists embedded in
adherent bacteria [59]. In this work, by using a competitive assay
we describe that hog1 cells adhere less efficiently to the mouse gut
mucosa, with a relative index of 0.67 versus 0.89 for wild type cells;
these effects are apparently mild, but could be crucial in vivo under
conditions in which the organism would have a physical or
temporal window for colonization competing with endogenous
microbiota. It has been described that hog1 mutants display an
altered sensitivity to cell wall interfering drugs [29] and how the
HOG pathway regulates to a certain extend the biogenesis of the
cell wall [34,35]. Moreover, proteomic and transcriptomal
analyses also revealed variations in cell wall proteins [68,69],
therefore providing a reasonable explanation for the altered
adhesion to host surfaces. Filamentation is enhanced in hog1
mutants under defined conditions [29] which can also alter
adhesion to certain surfaces. Therefore, reduced colonization can
result from a complete transcriptional program present in HOG
competent cells.
Additionally, a different host immune response against hog1
mutants may happen. It is interesting to note that, after hog1 levels
have notably decreased, boosting with the same strain (hog1-GFP)
did not follow the same pattern of colonization: it did not reach
previous high sustained CFU levels and the kinetic of loss was
much more pronounced (reduction of 1.24 versus 0.324 logarith-
mic units per day). We have also observed a slight impairment in
CAF2-RFP strain in initiating colonization after inoculation of
mice previously colonized with hog1-GFP strain. Those observa-
tions would suggest an induction of host adaptive defenses against
C. albicans colonization.
While further work is needed to better understand changes
occurring in C. albicans during in vivo colonization, the ability to use
specific C. albicans mutants defective in colonization but with a
transient passage through gut may lead to interesting approaches
in fields of vaccine and immunotherapy to fungal infections.
Supporting Information
Figure S1 Alignment of dTomato and C. albicans
adapted dTOM and dTOM2. An alignment between Shaner
original dTomato [47] and versions adapted to C. albicans dTOM
[70] and dTOM2 (this work) is shown. Alignment was generated
using the ClustalW server at EBI (http://www.ebi.ac.uk/Tools/
msa/clustalw2/). Numbers indicate nucleotide position number
relative to the own origin. Parameters were left to their default
values. (*) indicates a residue conserved in all sequences, (:)
indicates conservation between groups of strongly similar proper-
ties, (.) indicates conservation between groups of weakly similar
properties.
(TIF)
Figure S2 Growth behaviour of C. albicans expressing
either GFP or dTOM2 in vitro and in vivo. A) Correlation
between CFUs and FACS particle quantification. Samples
(n = 209) from several colonization assays were analysed by both
CFU counting and FACS particle quantification for gated
fluorescent populations. Logarithmic values obtained from each
sample were plotted and compared. B) Growth curve of CAF2 and
MAPK mutant strains expressing GFP or dTOM2. Cells were
diluted at O.D.600 = 0.1 from a stationary phase culture in YPD
medium supplemented or not with 20 mg/mL doxycycline. C)
Either a pure culture of CAF2-dTOM2 or a 1 1 population of
CAF2-dTOM2/CAF2-GFP were inoculated in SD medium at
O.D.600 = 0.1 and allowed to grow until stationary phase at 37uC.
Periodically (2–3 days), the culture was diluted again to the same
initial O.D. and the percentage of dTOM2 expressing cells (red
Figure 6. Mucosa adhesion and sensitivity to bile salts and
SDS. A) Samples of 10-fold dilutions from stationary growing cells were
spotted on YPD plates supplemented or not with 0.1% bile salts or 0.1%
SDS (as indicated) and incubated at 37uC for 48 hours before being
scanned. B) CAF2-dTOM2 was used as internal control to assess the
capability to adhere gut mucosa of CAF2-GFP (wt, circles), hog1-GFP
(hog1, triangles) and pbs2-GFP (pbs2, inverted triangles) strains. It is
represented as each single independent value and mean 6 standard
deviation (from three to five different experiments) of the Adhesion
Relative Index, that is calculated by dividing the adhered percentage of
cells from (CAF2, hog1 or pbs2)-GFP strains, recovered after 150 minutes
of interaction with gut mucosa, by their percentage in the inoculum.
*p,0.05.
doi:10.1371/journal.pone.0087128.g006
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colonies) was estimated out of the total number of CFUs. D)
Competition colonization assay with different fluorescent proteins.
CFUs are represented for each individual as red circles (CAF2-
dTOM2) or green circles (CAF2-GFP). Colored lines reflect the
tendency of the median of the respective strain. Oral antibiotic
therapy (streptomycin, bacitracin and gentamycin) was given to
mice (n = 3) from 4 days before the gavage of 107 cells of a 1 1
mixture of CAF2-dTOM2 and CAF2-GFP. CFUs were counted
and associated with each strain based on their pattern of FP
expression on solid SD plates.
(TIF)
Figure S3 Controls and strategy for in vivo gene
excision. A) C. albicans TET-ON expression during colonization
assay. C. albicans is represented for each individual as open circles
(population determined by CFU) or green circles (population
expressing GFP determined by FACS quantification). Lines reflect
the tendency of the median of the respective population. Oral
antibiotic therapy (streptomycin, bacitracin and gentamicin) was
given to mice (n = 2) from 4 days before a gavage of 107 cells of
CAF2-GFPind strain (day 0). Autoclaved chlortetracycline (1 mg/
mL aCT) was added to the standard antibiotic treatment to induce
the expression of GFP gene (yellow arrow). B) Schematic
representation of the genetic strategy to obtain a tetracycline-
dependent mutant for HOG1. C) in vitro excision of HOG1 ectopic
gene in the HOGcR strain. Cells were periodically diluted from a
stationary phase culture in YPD medium at O.D.600 = 0.1 and
25 mg/mL aCT was added to induce the expression of FLP gene
(yellow arrow). CFUs from each population are represented as
closed diamonds (wt phenotype) or open triangles (hog1 pheno-
type). Percentage of osmo-tolerant CFUs was determined based on
their pattern of osmo-sensitivity on 1.5 M sorbitol solid YPD
plates.
(TIF)
Figure S4 Sensitivity to bile salts and SDS of MAPK
mutants in C. albicans. Samples of 10-fold dilutions from
stationary growing cells were spotted on YPD plates supplemented
with 0.1% bile salts or SDS (as indicated) and incubated at 37uC
for 24 hours before being scanned.
(TIF)
Table S1 C. albicans strains used in this work. All C.
albicans strains used derive from the SC5314 clinical isolated.
Genotype and reference from each strain are indicated. A
nomenclature has been established for easily follow the text and
the figures.
(DOC)
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